scholarly article | Q13442814 |
P8978 | DBLP publication ID | journals/bioinformatics/MervinBKASFBEB18 |
P356 | DOI | 10.1093/BIOINFORMATICS/BTX525 |
P932 | PMC publication ID | 5870859 |
P698 | PubMed publication ID | 28961699 |
P50 | author | Lewis H Mervin | Q43370881 |
Ola Engkvist | Q43370883 | ||
P2093 | author name string | Fredrik Svensson | |
Avid M Afzal | |||
Ian Barrett | |||
Mike A Firth | |||
Krishna C Bulusu | |||
Leen Kalash | |||
P2860 | cites work | In silico methods to address polypharmacology: current status, applications and future perspectives | Q38689965 |
Carbonic anhydrase inhibitors. A general approach for the preparation of water-soluble sulfonamides incorporating polyamino-polycarboxylate tails and of their metal complexes possessing long-lasting, topical intraocular pressure-lowering properties. | Q43925029 | ||
Evaluating virtual screening methods: good and bad metrics for the "early recognition" problem. | Q51922697 | ||
Database resources of the National Center for Biotechnology Information | Q56337611 | ||
The ChEMBL bioactivity database: an update | Q27144224 | ||
Proteochemometric modelling coupled to in silico target prediction: an integrated approach for the simultaneous prediction of polypharmacology and binding affinity/potency of small molecules | Q27702464 | ||
Target prediction utilising negative bioactivity data covering large chemical space | Q27902317 | ||
Global analysis of small molecule binding to related protein targets | Q28478884 | ||
Target prediction for an open access set of compounds active against Mycobacterium tuberculosis | Q28534065 | ||
DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants | Q28584435 | ||
PubChem: a public information system for analyzing bioactivities of small molecules | Q28842768 | ||
In silico target predictions: defining a benchmarking data set and comparison of performance of the multiclass Naïve Bayes and Parzen-Rosenblatt window | Q30653633 | ||
Are phylogenetic trees suitable for chemogenomics analyses of bioactivity data sets: the importance of shared active compounds and choosing a suitable data embedding method, as exemplified on Kinases | Q30713425 | ||
Chemogenomic approaches to drug discovery: similar receptors bind similar ligands | Q33285994 | ||
Making every SAR point count: the development of Chemistry Connect for the large-scale integration of structure and bioactivity data | Q34056842 | ||
Identifying novel adenosine receptor ligands by simultaneous proteochemometric modeling of rat and human bioactivity data | Q34349853 | ||
Estimating error rates in bioactivity databases | Q35026552 | ||
Protein homology reveals new targets for bioactive small molecules | Q35611201 | ||
Identification of orthologous target pairs with shared active compounds and comparison of organism-specific activity patterns | Q35619832 | ||
Understanding Cytotoxicity and Cytostaticity in a High-Throughput Screening Collection | Q36115761 | ||
Global Mapping of Traditional Chinese Medicine into Bioactivity Space and Pathways Annotation Improves Mechanistic Understanding and Discovers Relationships between Therapeutic Action (Sub)classes | Q36644164 | ||
TargetHunter: an in silico target identification tool for predicting therapeutic potential of small organic molecules based on chemogenomic database | Q36910563 | ||
Tools for in silico target fishing | Q38256258 | ||
In silico assessment of adverse drug reactions and associated mechanisms | Q38566364 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P4510 | describes a project that uses | scikit-learn | Q1026367 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P1104 | number of pages | 8 | |
P304 | page(s) | 72-79 | |
P577 | publication date | 2018-01-01 | |
P1433 | published in | Bioinformatics | Q4914910 |
P1476 | title | Orthologue chemical space and its influence on target prediction | |
P478 | volume | 34 |
Q92191163 | In Silico Characterization of Structural Distinctions between Isoforms of Human and Mouse Sphingosine Kinases for Accelerating Drug Discovery |
Q64936713 | Leveraging heterogeneous data from GHS toxicity annotations, molecular and protein target descriptors and Tox21 assay readouts to predict and rationalise acute toxicity. |
Q58586423 | Systemic neurotransmitter responses to clinically approved and experimental neuropsychiatric drugs |
Q58586909 | Using Machine Learning to Predict Synergistic Antimalarial Compound Combinations With Novel Structures |
Search more.